| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.181 | 305.981 | 875.213 | 0 | - | - | - | - | - | - |
| Total Income - EUR | 1.181 | 305.981 | 875.213 | 0 | - | - | - | - | - | - |
| Total Expenses - EUR | 674 | 286.569 | 843.848 | 34.309 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 507 | 19.412 | 31.365 | -34.309 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 421 | 19.412 | 20.327 | -34.309 | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
Check the financial reports for the company - Avtamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Current Assets | 497.390 | 1.704.967 | 1.826.207 | 2.193.495 | - | - | - | - | - | - |
| Inventories | 191.766 | 949.674 | 253.883 | 537.850 | - | - | - | - | - | - |
| Receivables | 286.672 | 727.550 | 1.543.582 | 1.638.153 | - | - | - | - | - | - |
| Cash | 18.953 | 27.743 | 28.741 | 17.492 | - | - | - | - | - | - |
| Shareholders Funds | -33.436 | -13.683 | 10.269 | -24.229 | - | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | - | - | - | - | - | - |
| Debts | 530.826 | 1.718.650 | 1.815.937 | 2.217.723 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Avtamed Srl